Hitinder Gurm, MD
Cardiovascular Disease · Ann Arbor, MINPI 1841376597
Payments from drug & device makers
Across 21 payments — averaging $2470.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Osprey Medical Inc$27K
- Cardiovascular Systems Inc.$25K
Across 8 payments — averaging $5343.75 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Contego Medical, Inc$43K
What the payments were for
- Consulting fees$22,37583%
- Speaking & faculty fees$3,40013%
- Travel & lodging$9704%
- Food & beverage$1431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Osprey Medical Inc | 19 | $26,888 |
| Cardiovascular Systems Inc. | 2 | $25,000 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DyeVert$26,639
How this compares
$51,888 in reported general payments places this provider in the 85th percentile of 760 cardiovascular disease providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $11,394 |
| ClopidogrelClopidogrel Bisulfate | 38 | $605 |
| Rosuvastatin Calcium | 29 | $576 |
| Atorvastatin Calcium | 34 | $299 |
| Metoprolol Succinate | 36 | $261 |
| Lisinopril | 18 | $188 |
| Metoprolol Tartrate | 11 | $115 |
| Amlodipine Besylate | 15 | $100 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Ann Arbor
- Stanley ChetcutiAnn Arbor$4.3M
- Victor MolesAnn Arbor$2.1M
- Marschall RungeAnn Arbor$1.8M
- Sara SaberiAnn Arbor$1.6M
- Vallerie McLaughlinAnn Arbor$1.4M
- David BachAnn Arbor$390K
- Bertram PittAnn Arbor$298K
- Adam HelmsAnn Arbor$236K
- Salim HayekAnn Arbor$229K
- Brahmajee NallamothuAnn Arbor$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.